METHODS, COMPOSITIONS, AND DEVICES FOR SUPPLYING DIETARY FATTY ACID NEEDS
Nutritional formulas comprising long-chain polyunsaturated fatty acids (LC-PUFAs) are provided, along with methods and devices for preparing and/or administering nutritional formulas. In some embodiments, a percentage of the LC-PUFAs in the nutritional formula are in the form of monoglycerides and/or free fatty acids. In some embodiments, the nutritional formulas do not comprise added lipase. Also provided are methods for providing nutrition to a subject, methods for improving fat absorption, methods for improving cognitive ability, methods for preventing chronic lung disease, and methods for reducing the length of time a patient requires total parenteral nutrition.
1 .- 20 . (canceled)
21 . A method of preparing a nutritional composition for ingestion by a subject, the method comprising:
inserting a device into a container containing a nutritional composition, wherein the nutritional composition comprises triglycerides,
wherein the device comprises one or more walls forming an enclosure, wherein the one or more walls are permeable to the nutritional composition, and wherein the device contains immobilized lipase within the enclosure.
22 . The method of claim 21 , further comprising:
allowing the device to contact the nutritional composition for a period of time to allow the immobilized lipase to at least partially hydrolyze the triglycerides.
23 . The method of claim 22 , further comprising:
removing the device from the nutritional composition.
24 . The method of claim 23 , wherein the nutritional composition comprises no more than 0.02% (w/w) lipase following the removing step.
25 . The method of claim 22 , wherein the period of time is no more than 60 minutes.
26 . The method of claim 22 , wherein the period of time is no more than 30 minutes.
27 . The method of claim 22 , wherein the period of time is no more than 5 minutes.
28 . The method of claim 22 , wherein the nutritional composition is ready for ingestion after the allowing step.
29 . The method of claim 22 , wherein at least 20% of the triglycerides have been hydrolyzed into monoglycerides and/or free fatty acids after the allowing step.
30 . The method of claim 22 , wherein at least 40% of the triglycerides have been hydrolyzed into monoglycerides and/or free fatty acids after the allowing step.
31 . The method of claim 22 , wherein at least 60% of the triglycerides have been hydrolyzed into monoglycerides and/or free fatty acids after the allowing step.
32 . The method of claim 21 , further comprising:
agitating the nutritional composition.
33 . The method of claim 21 , wherein the device is a teabag-like structure.
34 . The method of claim 21 , further comprising providing the nutritional composition to a subject having at least one of Alzheimer's disease, bipolar disorder, depression, sepsis, acute respiratory stress, cancer, cardiovascular disease, stroke, Parkinson's disease, schizophrenia, diabetes, multiple sclerosis, malnutrition, impaired GI function, rheumatoid arthritis, systemic lupus erythematosus, inflammatory bowel disease, short bowel syndrome, irritable bowel disorder, Systemic Inflammatory Response Syndrome, celiac disease, Crohn's disease, Cystic Fibrosis, Zollinger-Ellison syndrome, hypertriglyceridemia, neoplasms, hemochromatosis, primary sclerosing cholangitis, primary biliary cirrhosis, diarrhea, Shwachman's syndrome, trypsinogen deficiency, enterokinase deficiency, chylothorax, isolated deficiency of lipase, premature birth, pancreatic insufficiency, pancreatitis, malabsorption, compromised pancreatic output, a reduced ability to hydrolyze triglycerides or esters, or a reduced ability to absorb triglycerides or esters.
35 . The method of claim 21 , further comprising providing the nutritional composition to a subject that is an infant.
36 . The method of claim 21 , wherein the immobilized lipase is immobilized by one or more of adsorption, ionic binding, covalent binding, cross-linking, encapsulation, or entrapment.
37 . The method of claim 21 , wherein the immobilized lipase is immobilized to a structure contained within the enclosure.
38 . The method of claim 37 , wherein the structure comprises at least one of particles, balls, or beads.
39 . The method of claim 21 , wherein the immobilized lipase is chosen from Chromobacterium viscosum, Pseudomonas fluorescens, Burcholderia cepacia , or Rhizopus oryzae.
40 . The method of claim 21 , wherein the one or more walls includes a mesh allowing for passage of liquid into and out of the enclosure.